Compagnie Lombard Odier SCmA trimmed its position in MetLife, Inc. (NYSE:MET – Free Report) by 5.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 307,298 shares of the financial services provider’s stock after selling 17,283 shares during the period. Compagnie Lombard Odier SCmA’s holdings in MetLife were worth $25,162,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. MeadowBrook Investment Advisors LLC boosted its holdings in MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares during the period. Carmichael Hill & Associates Inc. lifted its holdings in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 186 shares during the last quarter. Wolff Wiese Magana LLC lifted its holdings in shares of MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 277 shares during the last quarter. Peterson Financial Group Inc. bought a new stake in shares of MetLife during the 3rd quarter worth $30,000. Finally, Retirement Wealth Solutions LLC bought a new stake in shares of MetLife during the 4th quarter worth $32,000. 94.99% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on the stock. TD Cowen lifted their price objective on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a report on Wednesday. Wells Fargo & Company dropped their price objective on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a report on Tuesday, January 14th. BMO Capital Markets began coverage on shares of MetLife in a report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price objective for the company. Finally, Barclays lowered their price target on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $92.17.
MetLife Price Performance
MET stock opened at $82.41 on Friday. The firm’s 50-day moving average price is $83.54 and its two-hundred day moving average price is $81.00. MetLife, Inc. has a 12-month low of $67.30 and a 12-month high of $89.05. The stock has a market capitalization of $57.06 billion, a price-to-earnings ratio of 13.80, a PEG ratio of 0.64 and a beta of 1.07. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. As a group, equities analysts predict that MetLife, Inc. will post 9.63 earnings per share for the current year.
MetLife Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be given a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.65%. The ex-dividend date is Tuesday, February 4th. MetLife’s payout ratio is 36.52%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- Consumer Staples Stocks, Explained
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- How to Read Stock Charts for Beginners
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.